TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone-Reference-Cited by-同舟云学术

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone

Published:2018-12-20 Issue: Volume:12 Page:
ISSN:1662-5102
Container-title:Frontiers in Cellular Neuroscience
language:
Short-container-title:Front. Cell. Neurosci.

Author:

Zheng Cong,Chen Guiqin,Tan Yang,Zeng Weiqi,Peng Qiwei,Wang Ji,Cheng Chi,Yang Xiaoman,Nie Shuke,Xu Yan,Zhang Zhentao,Papa Stella M.,Ye Keqiang,Cao Xuebing

Publisher

Frontiers Media SA

Subject

Cellular and Molecular Neuroscience

Reference55 articles.

1. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function;Arvanitakis;Arch. Neurol.,2004

2. Effects of hypoperfusion in Alzheimer’s disease;Austin;J. Alzheimers Dis.,2011

3. Activation of asparaginyl endopeptidase leads to tau hyperphosphorylation in Alzheimer disease;Basurto-Islas;J. Biol. Chem.,2013

4. Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex;Beaudoin;Nat. Protoc.,2012

5. Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages;Borghammer;Brain Struct. Funct.,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Receptor modulators associated with the hypothalamus -pituitary-thyroid axis;Frontiers in Pharmacology;2023-12-04

2. Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal α-synuclein and oxidative stress in rotenone-induced Parkinson’s disease of male rats;PLOS ONE;2023-11-16

3. Activation of mGlu2/3 receptors in the striatum alleviates L-DOPA-induced dyskinesia and inhibits abnormal postsynaptic molecular expression;Pharmacology Biochemistry and Behavior;2023-10

4. Higher Peripheral Thyroid Sensitivity Is Linked to a Lower Risk of Heart Failure After Acute Myocardial Infarction;The Journal of Clinical Endocrinology & Metabolism;2023-04-27

5. Peptide and peptide-based drugs;Privileged Scaffolds in Drug Discovery;2023